Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -439,495 | -383,092 | -165,911 | -892,869 | -681,175 |
| Depreciation Amortization | 95,226 | 78,057 | 12,869 | 70,507 | 57,670 |
| Income taxes - deferred | N/A | N/A | N/A | -801 | N/A |
| Accounts receivable | -6,101 | -1,102 | -6,770 | 50,068 | 21,168 |
| Accounts payable and accrued liabilities | -31,099 | N/A | N/A | -1,183 | -4,822 |
| Other Working Capital | -91,849 | 6,192 | 312 | 29,837 | -12,219 |
| Other Operating Activity | 196,168 | 126,296 | 70,241 | 448,941 | 381,709 |
| Operating Cash Flow | $-277,150 | $-173,649 | $-89,259 | $-295,500 | $-237,669 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48,240 | -33,742 | -6,710 | -36,373 | -34,355 |
| Net Acquisitions | -5,400 | -5,400 | -5,400 | N/A | N/A |
| Purchase Of Investment | 3,951 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 538 | 191 | 0 | -44,320 | 336 |
| Investing Cash Flow | $-49,151 | $-38,951 | $-12,110 | $-80,693 | $-34,019 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -694 | -494 | -294 | -1,295 | -977 |
| Common Stock Issued | 84 | 84 | 70 | 93 | 79 |
| Other Financing Activity | -926 | -661 | -621 | -2,014 | -1,686 |
| Financing Cash Flow | $-1,536 | $-1,071 | $-845 | $-3,216 | $-2,584 |
| Exchange Rate Effect | -208 | -173 | -157 | -588 | -690 |
| Beginning Cash Position | 989,584 | 989,584 | 989,584 | 1,369,581 | 1,369,581 |
| End Cash Position | 661,539 | 775,740 | 932,724 | 989,584 | 1,094,619 |
| Net Cash Flow | $-328,045 | $-213,844 | $-56,860 | $-379,997 | $-274,962 |
| Free Cash Flow | |||||
| Operating Cash Flow | -277,150 | -173,649 | -89,259 | -295,500 | -237,669 |
| Capital Expenditure | -48,831 | -33,742 | -6,710 | -40,801 | -37,355 |
| Free Cash Flow | -325,981 | -207,391 | -95,969 | -336,301 | -275,024 |